医学
偏头痛
里扎曲普坦
光环
苏马曲普坦
特里普坦
佐米曲普坦
先兆偏头痛
人口
重症监护医学
儿科
内科学
兴奋剂
环境卫生
受体
作者
Stephen D. Silberstein,Sumit Patel
标识
DOI:10.1517/14656566.2014.947959
摘要
Introduction: In this article, we will discuss pure menstrual migraine without aura (PMM) and menstrually related migraine without aura (MRM). Depending on the frequency and severity of their attacks, patients with PMM will likely need an acute treatment and/or short-term preventive plan. Of note, with the use of acute treatments and short-term preventive therapy there is risk of medication overuse if the patient does have pure menstrual migraine and is being treated for menstrually related migraine.Areas covered: A PubMed, Cochrane Central, Medline, Ovid search provided articles relating to menstrual migraine pathophysiology and treatment.Expert opinion: Long-term daily preventive treatment should be considered for patients with MRM and those with severe PMM. Miniprophylaxis can be used in PMM rather than daily preventive treatment. When considering the use of short-term miniprophylaxis, sumatriptan, zolmitriptan, naratriptan, and frovatriptan have shown efficacy; however, frovatriptan appears to be the triptan of choice based on overall efficacy. Oral contraceptives may be considered if patients do not respond to or cannot tolerate typical migraine preventive medications. In patients with migraine with aura, oral contraceptives should be used with caution as this may add to the risk of stroke in this population.
科研通智能强力驱动
Strongly Powered by AbleSci AI